Sandoz Group AG (SWX:SDZ)
55.06
+0.74 (1.36%)
Nov 6, 2025, 10:43 AM CET
Sandoz Group AG Employees
Sandoz Group AG had 22,049 employees as of December 31, 2024. The number of employees decreased by 584 or -2.58% compared to the previous year.
Employees
22,049
Change (1Y)
-584
Growth (1Y)
-2.58%
Revenue / Employee
420.98K CHF
Profits / Employee
9.03K CHF
Market Cap
23.40B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 22,049 | -584 | -2.58% |
| Dec 31, 2023 | 22,633 | 895 | 4.12% |
| Dec 31, 2022 | 21,738 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Alcon | 25,599 |
| Lonza Group AG | 18,944 |
| Sonova Holding AG | 18,366 |
| Straumann Holding AG | 11,815 |
| Galenica AG | 7,971 |
| Galderma Group AG | 6,545 |
Sandoz Group AG News
- 1 day ago - Sandoz To Acquire Just-Evotec Biologics EU SAS In Strategic Biosimilars Expansion Deal - Nasdaq
- 1 day ago - Evotec (EVO) Sells Biologics Site to Sandoz for $350M - GuruFocus
- 1 day ago - Evotec signs deal with Sandoz for Just - Evotec Biologics site - Seeking Alpha
- 5 days ago - SDZNY vs. STVN: Which Stock Is the Better Value Option? - Nasdaq
- 6 days ago - Sandoz Group AG (SDZNY) Q3 2025 Sales Call Transcript - Seeking Alpha
- 7 days ago - Sandoz Group AG (SDZNY) Q3 2025 Sales/ Trading Statement Call - Slideshow - Seeking Alpha
- 26 days ago - FDA Gives Tentative Nod to Sandoz's Generic Version of Pfizer's Inlyta - GuruFocus
- 26 days ago - Sandoz granted tentative approval for generic of Pfizer's Inlyta - Seeking Alpha